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Objectives. We assessed relationships between sociodemographic character-
istics and mental health status and knowledge of, being worried about, and
stigmatization of 2 emerging infectious diseases: AIDS and SARS.
Methods. We conducted a random-digit-dialed survey of 928 residents of the
New York City metropolitan area as part of a study of the effects of the Septem-
ber 11, 2001, terrorist attacks. Questions added for this study concerned re-
spondents’ knowledge of, worry about, and support of stigmatizing actions to
control AIDS and SARS.
Results. In general, respondents with greater personal resources (income, ed-
ucation, social support) and better mental health status had more knowledge,
were less worried, and were less likely to stigmatize. This pattern held for both
AIDS and SARS.
Conclusions. Personal resources and mental health factors are likely to influ-
ence the public’s ability to learn about, rationally appraise the threat of, and min-
imize stigmatization of emerging infectious diseases such as AIDS and SARS.
(Am J Public Health. 2006;96:561–567. doi:10.2105/AJPH.2004.054742)
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Chang and colleagues found that “fear of
SARS” led to substantial reductions in seeking
medical care: a 23.9% reduction for ambula-
tory care, a 35.2% reduction for inpatient care,
and a 16.7% reduction for dental care.13 Pre-
sumably, people avoided seeking medical care
out of fear of becoming infected with SARS in
these medical settings. Studying the stigmatiza-
tion of SARS may provide us with insight into
the stigma associated with emerging infectious
diseases and the potential consequences of
such stigmatization.
A potentially useful model for considering
stigmatization of SARS and other newly
emerging infectious diseases may be found
in the work of Pryor et al.14 They suggest a 2-
factor theory of HIV- related stigma: (1) an
immediate affective reaction, based on multi-
ple negative qualities associated with the dis-
ease (e.g., death, promiscuity, drug use, homo-
sexuality), possibly followed by (2) a cognitive
rule-based system that ameliorates stigmatiza-
tion “if perceivers have enough time, motiva-
tion, and cognitive resources.”14(p1189) Within
this formulation, availability of additional in-
formation about the disease should lead to a
reduction in stigmatization. This prediction is
consistent with the activities of many public
health authorities who hope to reduce stigma-
tization through increased public education
on diseases such as AIDS.
We compared stigmatizing attitudes toward
AIDS and SARS in a representative sample
of persons living in the New York City (NYC)
metropolitan area and examined factors asso-
ciated with these attitudes.
METHODS
Participants
We obtained data from a cohort of persons
who were living in the NYC metropolitan area
on September 11, 2001. Briefly, the cohort
was recruited through a random-digit-dialed
telephone survey between March 25 and
June 25, 2002, for the purpose of under-
standing the consequences of the September
11 terrorist attacks in the NYC area. The sam-
pling frame consisted of all adults (aged 18
years and older) in the NYC metropolitan
area. (Additional details are provided else-
where.15) Interviews were conducted in Eng-
lish, Spanish, Mandarin, and Cantonese by
trained interviewers using translated and
back-translated questionnaires and a computer-
assisted telephone interview system. In each
Both the fear of people who are different and
the fear of disease can lead to social stigmati-
zation.1 Occasionally these fears co-occur, re-
sulting in severe stigmatization of strangers
with diseases. Such stigmatization can in-
crease the adverse consequences of a disease
in multiple ways. First, stigmatization can sub-
stantially increase the suffering of persons
with the disease. Second, persons with or at
risk for the disease may avoid seeking health
care, making it much harder for public health
authorities to control the disease. Third, pro-
fessionals and volunteers working in the field
may also become stigmatized, leading to
higher rates of stress and burnout.2 Finally,
stigmatization may generate considerable
economic losses if people avoid groups or ge-
ographic areas associated with the disease.
Many diseases have been stigmatized
throughout history. For example, persons with
the plague were stigmatized during the Middle
Ages, and sexually transmitted diseases have
been stigmatized throughout the last several
centuries.3,4 Acquired immunodeficiency syn-
drome (AIDS) has been one of the most feared
and stigmatized diseases of the last 20 years.
There is abundant evidence that the stigmati-
zation of AIDS has been detrimental to the
health of those with AIDS and has played a
role in limiting public health and medical ef-
forts to control the disease.5,6 For example,
early stigmatization of AIDS as a disease of
homosexual men contributed to low levels of
funding for AIDS research in the1980s.3,4,7
Over the last several years, severe acute res-
piratory syndrome (SARS) has emerged as a
new feared disease associated with strangers
(Asians, particularly Chinese) and has gener-
ated considerable stigmatization.8,9 Reduced
travel to SARS-affected areas clearly led to
large economic losses for those areas,10,11 but
there has been relatively little systematic re-
search on fear of SARS or stigmatization of
persons with or at risk for the disease.12 In
one study of medical access patterns in Taiwan,
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eligible household, the adult whose birthday
was closest to the interview date was chosen
to participate. Up to 10 attempts were made
to conduct the interview. The response rates
among those eligible for survey participation
were 56% in the metropolitan area and 60%
in New York City itself.
Contact information for follow-up inter-
vews was obtained from respondents and
their key family members. Follow-up was con-
ducted between September 25, 2002, and
January 31, 2003, and between September
24, 2003, and February 29, 2004. We com-
pleted follow-up interviews with 1832 (67%)
of the 2748 baseline respondents during the
second follow-up, at which time we asked the
questions reported on here. Each participant
received a nominal $10 incentive to partici-
pate in each survey wave, and each interview
was approximately 35 minutes long.
Survey Instrument
Demographic data for this analysis came
from the baseline interview, during which we
collected information on respondents’ age,
race/ethnicity, gender, and education. Data
about self-assessed knowledge of and attitudes
toward SARS and AIDS were collected from a
randomly selected subset of participants in the
second cohort follow-up. These questions were
modified from previous work (J. Ahern, J. Stu-
ber, and S. Galea, unpublished data, 2005).
We first asked if the respondent had heard
about SARS; those who said yes were asked if
they had heard “a great deal,” “some,” or “not
much” about the disease. We then asked re-
spondents who had heard about SARS how
much they agreed or disagreed with each of
the following statements as a method for con-
trolling the disease: “requiring Americans with
SARS to wear identification tags,” “the govern-
ment announcing it will execute people who
knowingly spread SARS,” “quarantining or sep-
arating all people with SARS from others in the
United States,” “avoiding areas in the United
States that are heavily populated by Chinese,”
“forcing all Chinese people to be medically
checked for SARS,” and “not allowing Chinese
people to enter the United States.” An addi-
tional statement concerned whether people
who developed the disease could be blamed:
“People with SARS got what they deserved.”
Response options were “agree strongly,” “agree
somewhat,” “disagree somewhat,” or “disagree
strongly.” We asked equivalent questions about
AIDS, substituting “HIV or AIDS” for “SARS”
and “gay men” for “Chinese.”
We also constructed a summary stigmatiza-
tion scale for each disease by summing the
responses to the 6 questions about stigmatiz-
ing methods of controlling the disease. The
Cronbach α was 0.80 for the AIDS stigmati-
zation scale and 0.72 for the SARS stigmati-
zation scale. We also asked respondents how
worried they were about contracting SARS
or AIDS— “not at all worried,” “somewhat
worried,” or “very worried.”
We were interested in whether worry and
stigmatization were associated with psycholog-
ical conditions such as depression. To assess
depression, we used an adapted version of the
major depressive disorder scale from the non-
patient version of the structured clinical inter-
view for the Diagnostic and Statistical Manual
of Mental Disorders, Revised Third Edition
(DSM III-R ),16 which has been used in other
population studies.17,18 We followed DSM-IV
guidelines, considering that respondents met
the criteria for depression if they had experi-
enced 5 or more symptoms for at least 2
weeks. We also asked when was the last time
the respondent experienced these symptoms.
The Cronbach α for the 8 symptoms used in
this scale was 0.79.19 We asked about depres-
sive symptoms in the previous 12 months and
in the 1 month before the interview.
Analyses
We used means to summarize responses to
each of the questions about AIDS and SARS
attitudes and then assessed the correlations
between responses. We used χ2 tests, t tests,
and Pearson correlations to assess relation-
ships between various factors and knowledge
of and attitudes toward AIDS and SARS. The
analyses were weighted to correct potential
selection bias related to the number of house-
hold telephones, the number of persons in
the household, and oversampling, as well as
to make the sample demographically similar
to the NYC metropolitan area population ac-
cording to 2000 US Census estimates. We
used SUDAAN software (release 8.0; Re-
search Triangle Institute, Research Triangle
Park, NC) to estimate standard errors and to
adjust analyses for weighting.
RESULTS
The sample was weighted to approximate the
2000 US Census data for the NYC metropolitan
area: 45% male, 55% female; 54% White,
19% African American, 5% Asian, 20% His-
panic, 3% other; 11% aged 18 through 24
years, 26% aged 25 through 34 years, 21%
aged 35 through 44 years, 18% aged 45
through 54 years, 12% aged 55 through 64
years, and 12% aged 65 years or older.
Table 1 shows the means for the responses
to the questions on AIDS and SARS and the
correlations between the AIDS and SARS re-
sponses. The means were quite similar for both
sets of responses. There was only 1 question
with a 1-point difference in the means: there
was substantially more agreement on quaran-
tining people with SARS than on quarantining
people with AIDS (t=–38.8; P<.0001). Thus,
given the modes of transmission and length of
incubation period for the 2 diseases, quaran-
tine would be an acceptable public health mea-
sure for controlling SARS, but not AIDS, in
New York City. There was a 0.5-point differ-
ence between mean responses to the question
“How much have you heard about [AIDS/
SARS]?” Respondents reported having heard
more about AIDS than about SARS (t=25.2;
P<.0001). There was relatively little agree-
ment with the “blaming” question (“People with
[AIDS or SARS] got what they deserved”) for
either AIDS or SARS (means of 1.23 and 1.11,
respectively, on a scale of 1 [disagree strongly]
to 4 [agree strongly]).
The correlations between responses to the
AIDS questions and responses to the SARS
questions were statistically significant for all
questions and ranged from a low of 0.14, for
allowing gay men or Chinese into the coun-
try, to a high of 0.71, for executing persons
who knowingly spread AIDS or SARS. The
correlation for the question on being worried
about getting AIDS/SARS was significant but
modest at 0.29.
Responses to the questions concerning rela-
tively extreme forms of stigmatization (requir-
ing persons with the disease to wear identifi-
cation tags, executing persons who knowingly
spread the disease, forcing all gay men to be
checked for AIDS or Chinese for SARS) were
highly correlated, with correlation coefficients
between 0.51 and 0.71. The correlation for
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TABLE 1—Mean Responses to Survey Questions About AIDS and SARS: New York City
Metropolitan Area, 2003 (n=928)
Mean Response, Mean Response,
AIDS SARS r
How much have you heard about AIDS (SARS)?a 3.78 3.26 0.327
Should Americans with AIDS (SARS) be required to wear identification tags?b 1.77 1.93 0.674
Should people who knowingly spread AIDS (SARS) be executed?b 1.92 1.71 0.710
Should people in the United States with AIDS (SARS) be quarantined?b 1.62 3.00 0.287
Should people avoid areas in the United States heavily populated by 1.68 1.70 0.339
gay men (Chinese)?b
Should all gay men (Chinese) be forcibly checked for AIDS (SARS)?b 2.24 2.12 0.508
Should gay men (Chinese) not be allowed to enter the United States?b 1.43 1.68 0.138
Did people with AIDS (SARS) get what they deserve?b 1.23 1.11 0.492
How worried are you about getting AIDS (SARS)?c 1.34 1.49 0.288
Note. Parenthetical wording pertains only to questions regarding SARS. All Ps < .0001.
aCoded from 2 (not much) to 4 (a great deal).
bCoded from 1 (disagree strongly) to 4 (agree strongly).
cCoded from 1 (not at all) to 3 (very).
the question on blaming persons with the dis-
ease (“They got what they deserved”) was
also relatively high (0.49).
There were few significant associations be-
tween sociodemographic variables (age, gen-
der, and race/ethnicity) and knowledge of
and attitudes toward AIDS and SARS. Youn-
ger respondents (younger than 45 years) and
Whites were less likely than others to express
stigmatizing attitudes toward AIDS. Younger
respondents were more likely than older re-
spondents to report being “somewhat” or
“very” worried about getting AIDS, and
women were more likely than men to report
that they were “somewhat” or “very” worried
about getting SARS. Whites were less likely
than those of other races to be concerned
about getting AIDS and SARS (data available
from the first author).
As shown in Table 2, educational level was
related to almost all of the responses on the
AIDS and SARS questions. There were multi-
ple significant relationships between higher
educational levels and decreased agreement
with the stigmatizing methods of controlling
the diseases. The relationships were generally
negative, with more educated respondents ex-
pressing less agreement with the stigmatizing
methods of disease control. The question on
the use of quarantine was a notable exception
to this general pattern.
Table 3 shows, for each disease, correla-
tions between knowledge (“heard about”), the
summary stigmatization scale, blaming, and
being worried about getting the disease.
There were consistent patterns among knowl-
edge, stigmatization, blaming, and worry for
both diseases. Greater knowledge was mod-
estly associated with less stigmatization and
less blaming. Within the group of respondents
who were “very worried” about getting either
disease, however, having heard more about
the disease was associated with greater
stigmatization (r =0.26 for AIDS, r =0.16 for
SARS; both Ps> .05).
Table 4 shows associations between con-
cern about getting AIDS or SARS and having
experienced symptoms of depression in the
year before the interview. All of the associa-
tions were of positive-response form, with
higher rates of depression within each cate-
gory of increasing worry. In a cross-sectional
study we cannot ascertain the direction of
cause and effect.
DISCUSSION
We found a number of similarities be-
tween attitudes toward AIDS and attitudes
toward SARS. Some sociodemographic char-
acteristics, especially lower educational lev-
els, were associated with endorsement of a
variety of stigmatizing methods for the con-
trol of each disease. Increasing levels of
worry about getting each disease were asso-
ciated with depression.
Similarities and Differences Between
AIDS and SARS
There are several strong similarities be-
tween AIDS and SARS from a psychological
perspective, suggesting that they may serve as
a model for stigmatizing attitudes toward seri-
ous emerging infectious diseases in general.
Both AIDS and SARS are relatively new, both
are fatal for a high percentage of persons who
develop the disease, and both are associated
with “stranger” groups (gay men and injection
drug users for AIDS, Asians in general and
Chinese in particular for SARS). However,
there are very important differences in the
epidemiology of the 2 diseases, and New York
City’s experiences with AIDS and SARS have
been radically different.
HIV/AIDS has truly been a public health
catastrophe for the city, with a cumulative total
of 122062 cases of AIDS20 and an estimated
3105 new HIV infections per year in the city at
the time of data collection (September 2003).21
In contrast, there were only 9 cases of SARS
reported in the metropolitan area, there was no
known local transmission of SARS, and by the
time of data collection the World Health Orga-
nization had officially declared that SARS had
been contained globally.22 The modes of trans-
mission (and thus, the ability of an individual to
avoid infection) are also quite different for the
2 diseases—primarily sexual and blood-to-blood
contact for AIDS, and primarily droplet trans-
mission for SARS.
This study showed great consistency in
attitudes toward both diseases, suggesting
that the psychological similarities between
the 2 diseases may be more important in
shaping attitudes toward them than the epi-
demiological differences. For example, the
means of responses on the “worried” ques-
tion were almost identical for the 2 diseases
(approximately 1.5 on a 3-point scale from
“not at all worried” to “very worried”). The
associations between educational level and
attitudes toward the diseases were nearly
identical as well. Also, for each disease
there were relatively high correlations be-
tween the severe stigmatization questions
American Journal of Public Health | March 2006, Vol 96, No. 3564 | Research and Practice | Peer Reviewed | Des Jarlais et al.
 RESEARCH AND PRACTICE 
TABLE 2— Survey Respondents’ Knowledge and Attitudes About AIDS and SARS, by Educational Attainment: 
New York City Metropolitan Area, 2003 (n=928)
AIDS SARS
Not Some/a Not Not Some/a Not 
much, great Agree, Disagree, at all, Somewhat, Very, much, great Agree, Disagree, at all, Somewhat, Very,
Question % deal,% % % % % % P % deal,% % % % % % P
How much have you heard about 
AIDS (SARS)?
<High school 6.0 94.0 .215 22.0 78.0 .224
High school or equivalent 6.4 93.6 18.1 82.0
Some college 1.6 98.4 13.2 86.8
College degree 4.7 95.3 11.3 88.7
Graduate work 0.7 99.4 7.4 92.6
Should Americans with AIDS 
(SARS) be required to wear 
identification tags?
<High school 47.6 52.4 .0003 38.2 61.8 .010
High school or equivalent 33.5 66.5 37.6 62.4
Some college 21.2 78.8 28.8 71.2
College degree 21.6 78.4 25.4 74.6
Graduate work 10.4 89.6 12.4 87.6
Should people who knowingly 
spread AIDS (SARS) be 
executed?
<High school 45.0 55.0 .005 28.6 71.4 .315
High school or equivalent 36.4 63.7 20.8 79.2
Some college 29.0 71.0 25.5 74.5
College degree 24.8 75.3 20.2 79.8
Graduate work 15.0 85.0 12.7 87.3
Should people in the United 
States with AIDS (SARS) 
be quarantined?
<High school 34.8 65.3 .0002 55.4 44.6 .091
High school or equivalent 25.6 74.4 73.3 26.7
Some college 19.4 80.6 76.0 24.0
College degree 11.8 88.2 73.6 26.4
Graduate work 6.1 93.9 60.9 39.1
Should people avoid areas in the 
United States heavily 
populated by gay men 
(Chinese)?
<High school 30.9 69.1 .001 16.0 84.0 .009
High school or equivalent 25.4 74.6 22.1 77.9
Some college 23.3 76.7 20.8 79.2
College degree 12.4 87.6 19.8 80.2
Graduate work 7.2 92.8 5.5 94.5
Continued
and blaming people with the disease. This
suggests that the responses to these ques-
tions may be relatively independent of the
specific characteristics of AIDS and SARS,
including the objective likelihood of con-
tracting the diseases.
Zajonc has described the “primacy of af-
fect” in psychological processes,23 and our
findings do strongly suggest that the negative
emotions aroused by the 2 diseases generate
similar patterns of stigmatization and override
the differences in their epidemiology.
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TABLE 2—Continued
Should all gay men (Chinese) be 
forcibly checked for AIDS 
(SARS)?
<High school 77.9 22.1 <.0001 48.6 51.4 <.0001
High school or equivalent 53.4 46.7 48.7 51.3
Some college 43.1 56.9 38.9 61.2
College degree 34.9 65.1 26.2 73.8
Graduate work 17.4 82.6 11.0 89.0
Should gay men (Chinese) not be 
allowed to enter the 
United States?
<High school 9.7 90.3 .012 28.1 72.0 .002
High school or equivalent 14.8 85.2 20.8 79.3
Some college 13.4 86.6 25.8 74.2
College degree 5.4 94.6 12.2 87.8
Graduate work 3.2 96.8 6.2 93.8
Did people with AIDS (SARS) get 
what they deserve?
<High school 6.5 93.5 .121 3.5 96.5 . . .
High school or equivalent 7.0 93.0 2.7 97.3
Some college 5.3 94.7 0.8 99.2
College degree 1.7 98.3 0.0 100.0
Graduate work 6.9 93.1 0.0 100.0
How worried are you about 
getting AIDS (SARS)?
<High school 59.2 22.0 18.9 <.0001 53.3 33.4 13.3 .098
High school or equivalent 64.6 25.0 10.4 53.6 42.9 3.6
Some college 66.7 31.9 1.4 48.9 43.9 7.2
College degree 71.1 26.9 2.0 56.6 38.6 4.9
Graduate work 86.2 12.8 1.0 70.9 27.4 1.7
Note. Parenthetical wording pertains only to questions regarding SARS.
Stigmatization of Emerging Infectious
Diseases
People with diseases appear to have been
stigmatized throughout history. This stigmati-
zation and the resulting social shunning may
have served to reduce transmission of infec-
tious diseases in the past, and quarantine and
avoidance of people and places associated
with a disease may still be useful in control-
ling some diseases. With emerging infectious
diseases in the context of economic globaliza-
tion, however, stigmatization and the fear of
stigmatization may also actively increase the
spread of the diseases. Individuals with or
at risk for stigmatized diseases may avoid
seeking health care in order to avoid being
stigmatized. Governments may attempt to
suppress information about emerging infec-
tious diseases in their jurisdictions because
of the potentially severe economic conse-
quences associated with stigmatization of an
infectious disease. Thus, in the current era,
control of emerging infectious diseases will
require that we increase our ability to ame-
liorate the stigmatization associated with
such diseases.
Reducing Stigmatization of AIDS 
and SARS
Public health authorities have used a
variety of methods to attempt to reduce
stigmatization associated with HIV/AIDS.24
These methods have included (1) basic pub-
lic education about HIV/AIDS, such as na-
tional mailing of an informational pamphlet
from the US surgeon general; (2) mass
media (print, radio, and television) cam-
paigns; (3) publicized symbolic acts by
public leaders indicating that there is no
need to fear people and places associated
with the disease, such as pictures of the US
president with AIDS patients; (4) creating or
invoking laws or policies prohibiting stigma-
tization and discrimination, such as invoking
the Americans with Disabilities Act to pro-
tect the rights of people with HIV/AIDS;
and (5) drawing attention to sympathetic
people with AIDS, such as Ryan White.
These efforts have been partially success-
ful. National probability sample telephone
surveys conducted throughout the 1990s5
showed that overt expressions of stigmatiza-
tion declined over time. However, inaccurate
beliefs, such as a belief in transmission via
casual contact, and punitive beliefs (that peo-
ple with HIV/AIDS deserved the disease) in-
creased. In 1999, one third of the sample
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TABLE 3—Correlations Between Survey Respondents’ Knowledge and Attitudes About AIDS and SARS,
Overall and by Degree of Worry About Getting the Disease: New York City Metropolitan Area, 2003 (n=928)
AIDS (n = 917) SARS (n = 863)
People With People With 
How Much the Disease How Much the Disease 
Heard About Stigmatization Got What Heard About Stigmatization Got What 
the Diseasea Scaleb They Deservec the Diseasea Scaleb They Deservec
r P r P r P r P r P r P
Stigmatization scaleb –0.177 <.0001 . . . . . . . . . . . . –0.160 <.0001 . . . . . . . . . . . .
People with the disease got what they deservec –0.117 .0004 0.349 <.0001 . . . . . . –0.216 <.0001 0.208 <.0001 . . . . . .
How worried about getting the diseased –0.035 .290 0.170 <.0001 0.028 .402 0.027 .423 0.213 <.0001 0.039 .249
Not at all worried about getting the disease
AIDS (n = 669) SARS (n = 498)
Stigmatization scaleb –0.203 <.0001 . . . . . . . . . . . . –0.134 .003 . . . . . . . . . . . .
People with the disease got what they deservec –0.141 .0003 0.375 <.0001 . . . . . . –0.191 <.0001 0.208 <.0001 . . . . . .
Somewhat worried about getting the disease
AIDS (n = 199) SARS (n = 318)
Stigmatization scaleb –0.209 .003 . . . . . . . . . . . . –0.276 <.0001 . . . . . . . . . . . .
People with the disease got what they deservec –0.096 .182 0.311 <.0001 . . . . . . –0.274 <.0001 0.216 .0001 . . . . . .
Very worried about getting the disease
AIDS (n = 45) SARS (n = 45)
Stigmatization scaleb 0.258 .091 . . . . . . . . . . . . 0.155 .311 . . . . . . . . . . . .
People with the disease got what they deservec –0.150 .332 0.197 .205 . . . . . . –0.086 .575 0.103 .502 . . . . . .
Note. Ns do not fully add up because of missing data.
a Coded 2 (not much) to 4 (a great deal).
b Coded 6 (less stigmatization) to 24 (more stigmatization).
c Coded 1 (disagree strongly) to 4 (agree strongly).
d Coded 1 (not at all worried) to 3 (very worried).
TABLE 4—Associations Between Depression and Worry About Getting AIDS or SARS: 
New York City Metropolitan Area, 2003
Worried About Getting AIDS Worried About Getting SARS
Symptoms of Symptoms of Symptoms of Symptoms of 
Depression in Depression in Depression in Depression in 
Past Year Past Month Past Year Past Month
How Worried No. (%) P No. (%) P No. (%) P No. (%) P
Not at all 75 (8.6) .0003 37 (4.5) .039 54 (8.0) .015 26 (3.8) .054
Somewhat 52 (19.4) 22 (10.0) 58 (15.3) 27 (7.8)
Very 13 (30.8) 6 (13.7) 12 (22.9) 5 (15.7)
Note. “No.” reflects the actual count of respondents in each cell; “%” is the percentage of people reporting different levels of
depression symptoms within the categories of worry about the disease. This percentage is based on the weighting procedures
described in Methods.
expressed negative reactions to and discom-
fort with people with HIV.
There have been some attempts to reduce
fear and stigmatization of SARS, such as public
education campaigns.25,26 There has also been
a concerted attempt by health officials world-
wide to keep the public informed of new de-
velopments regarding SARS, including the
occurrence of infections through laboratory
accidents.27,28 Determining whether these ef-
forts have been effective will require additional
research.
Our data indicate some potential effective-
ness of providing accurate information to the
public as a strategy to reduce stigmatization.
For both AIDS and SARS, the more subjects
had heard about the disease, the less likely they
were to express stigmatizing attitudes. How-
ever, some limitations of this strategy were also
indicated. For the subgroup who were “very
worried” about contracting the diseases, having
heard more about the diseases was not associ-
ated with less stigmatization. Additionally,
being depressed was associated with being
worried about the diseases, suggesting that
there may be important nonrational linkages
between a person’s general emotional status
and his or her reaction to emerging diseases.
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Interestingly, there also appears to be a
carryover in time of worry about these types
of diseases. Our data were collected after
SARS was officially declared contained by the
World Health Organization, but many of our
respondents were still worried about contract-
ing the disease. Indeed, the level of worry
about contracting SARS was equal to the
level of worry about contracting AIDS.
Limitations
There seems to be little doubt that both
AIDS and SARS could evoke stigmatizing be-
haviors, which we were not able to directly
assess. Actual enactment of stigmatizing be-
haviors may depend upon a variety of situa-
tional factors in addition to the possession of
stigmatizing attitudes. Whether the patterns
of stigmatizing behaviors would be similar for
the 2 diseases remains to be addressed.
Our study was an exploratory effort added
to an existing telephone survey. The time that
we could add to the existing interview was
limited, and some variables had to be mea-
sured with single questions. We did not have
prior work from which to formulate hypothe-
ses and, thus, did not attempt multivariate
analyses for testing hypotheses. Most of the
correlation coefficients we observed were in
the range of 0.3 to 0.7. Although these were
highly significant, given our sample size, these
coefficients correspond to between 10% and
50% of variance explained in the dependent
variable. We expect that in future research, it
will be possible to develop formal multivari-
ate models that will explain higher percent-
ages of variance in the dependent variables.
Conclusions
The data reported here concern AIDS and
SARS, 2 “naturally occurring” infectious dis-
eases. Whether the same stigmatization
processes would occur in the context of a
bioterrorist attack using infectious agents is
an important issue for further investigation.
Additional new infectious diseases are
likely to emerge in the coming years, some of
which will arise in foreign countries and
spread through international air travel. Some
will also have high fatality rates. Many differ-
ent strategies will be needed to control these
new diseases, from improved laboratory facili-
ties to better communication networks among
health authorities in different countries. Bet-
ter methods for ameliorating the fear and
stigmatization associated with these diseases
are also needed, and we suggest that this be
considered an urgent matter for additional
research.
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